-
Stemline Therapeutics: Post-ASH Update For This Leader In The CD123 Space
Post on 12/12/19
-
Merck: Adding To The Pipeline
Post on 12/11/19
-
Intercept Pharmaceuticals: Blockbuster Therapy Unveils An Upside Catalyst
Post on 12/11/19
-
Here's Why Intercept Pharmaceuticals Stock Rose 48.9% in November
Post on 12/11/19
-
Rocket Pharmaceuticals Proposes Public Offering of Common Stock
Post on 12/11/19
-
Rocket Pharmaceuticals Prices Public Offering of Common Stock
Post on 12/11/19
-
Health System Opens Specialty Center With Same-Day Diagnosis, Testing, And Treatment
Post on 12/10/19
-
LEO Pharma Joins Certara’s PBPK Simcyp Simulator Consortium
Post on 12/10/19
-
MetLife Named One of America’s Most Responsible Companies
Post on 12/10/19
-
Canepa Healthcare changes Name to Evidity Health Capital
Post on 12/10/19
-
SCYNEXIS Announces Pricing of $35 Million Public Offering
Post on 12/10/19
-
Amneal To Acquire Majority Interest in AvKARE
Post on 12/10/19
-
Current Health Closes $11.5 Million Series A Funding Round
Post on 12/10/19
-
Immunomedics Closes Public Offering of Common Stock
Post on 12/9/19
-
Akers BioSciences Closes Approximately $8 Million Public Offering
Post on 12/9/19
-
Relmada Therapeutics Closes $115M Public Offering of Common Stock
Post on 12/9/19
-
SCYNEXIS Announces Launch of Public Offering of Common Stock
Post on 12/9/19
-
Quest Diagnostics Prices $800 Million of Senior Notes
Post on 12/9/19
-
HSS Extends Global Network to Colombia with New Collaboration
Post on 12/9/19
-
Zentalis Pharmaceuticals Raises $85 Million in Oversubscribed Series C
Post on 12/9/19
-
Bristol-Myers Squibb Prescribed For The Newborn Portfolio
Post on 12/9/19
-
Bristol Myers Squibb: A Cash-Generating Machine at a Cheap Price
Post on 12/9/19
-
Better Buy: Pfizer vs. Bristol-Myers Squibb
Post on 12/9/19
-
Antares Pharma Social Media Campaign for XYOSTED Wins MarCom Platinum Award
Post on 12/8/19
-
IVERIC bio Prices Public Offering of Common Stock
Post on 12/8/19